Skip to main content
. 2022 Mar 26;11(7):1835. doi: 10.3390/jcm11071835

Figure 1.

Figure 1

Study design. A total of 99 patients with CLD were included in this study. None of the included patients had any history of coagulopathy, sepsis, or platelet disorders. We investigated the relationship(s) among ADAMTS13:AC, VWF:Ag, and parameters related to Et in patients with CLD to determine the cause of the imbalance between ADAMTS13:AC and VWF:Ag in these patients. CLD, chronic liver diseases; ADAMTS13, a disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13; ADAMTS13:AC, ADAMTS13 activity; VWF, von Willebrand factor; VWF:Ag, VWF antigen; Et, endotoxins.